share_log

An Overview of Corvus Pharma's Earnings

An Overview of Corvus Pharma's Earnings

Corvus Pharma收入概况
Benzinga ·  2024/11/11 22:01

Corvus Pharma (NASDAQ:CRVS) is set to give its latest quarterly earnings report on Tuesday, 2024-11-12. Here's what investors need to know before the announcement.

Corvus Pharma(纳斯达克:CRVS)计划于2024年11月12日星期二发布最新的季度财报。投资者在公布之前需要了解的内容如下。

Analysts estimate that Corvus Pharma will report an earnings per share (EPS) of $-0.10.

分析师估计,Corvus Pharma的每股收益(EPS)将达到-0.10美元。

The announcement from Corvus Pharma is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

投资者急切期待Corvus Pharma的公告,希望了解是否能超越预期并获得下一季度的良好指引。

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

值得注意的是,对于新投资者来说,指导可能是股票价格波动的关键因素。

Overview of Past Earnings

过去收益的概述

In the previous earnings release, the company beat EPS by $0.05, leading to a 9.67% increase in the share price the following trading session.

在上一次财报公布中,公司每股收益超出0.05美元,导致股价在接下来的交易日上涨了9.67%。

Here's a look at Corvus Pharma's past performance and the resulting price change:

让我们回顾一下Corvus Pharma的过往表现及其导致的股价变动:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate -0.12 -0.11 -0.12 -0.12
EPS Actual -0.07 -0.12 -0.14 -0.12
Price Change % 10.0% -12.0% -6.0% 1.0%
季度 2024年第二季度 2024年第一季度 Q4 2023 Q3 2023
每股收益预估值 -0.12 -0.11 -0.12 -0.12
每股收益实际值 -0.07 -0.12 -0.14 -0.12
价格变更% 10.0% -12.0% -6.0% 1.0%
bigjpg

Corvus Pharma Share Price Analysis

Corvus Pharma股价分析

Shares of Corvus Pharma were trading at $9.45 as of November 08. Over the last 52-week period, shares are up 538.51%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.

截至11月8日,Corvus Pharma股票交易价为9.45美元。在过去52周内,股票上涨了538.51%。考虑到这些回报通常是积极的,长期股东在这份财报发布前应感到满意。

To track all earnings releases for Corvus Pharma visit their earnings calendar on our site.

要追踪Corvus Pharma的所有财报发布,请访问我们网站上的财报日历。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文是由Benzinga的自动内容引擎生成,并由编辑审核。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发